ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited (RAD)

0.026
-0.001
( -3.70% )
Updated: 19:30:33

Radiopharm Theranostics Limited Financial Summary

The current RAD market cap is 11.75M. The company's latest EPS is AUD -0.1061 and P/E is -0.28.

Year End June 29 2024 2021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 09k6.21M1.96M
Operating Income -484k-19.92M-33.81M-45.67M
Net Income -485k-30.42M-34.61M-47.95M
Year End June 29 2024 2021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 33k83.38M74.95M72.04M
Total Liabilities 158k20.42M29.37M44.68M
Total Equity -125k62.96M45.58M27.35M

Cash Flow

Year End June 29 2024 2021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating -33k-9.91M-23.2M-22.98M
Investing N/A -28.38M-1.53M N/A
Financing 60k65.11M9.22M29.88M
Market Cap 11.75M
Price to Earnings Ratio -0.28
Price to Sales Ratio 6.98
Price to Cash Ratio 0.73
Price to Book Ratio 0.5
Dividend Yield -

Share Statistics

Shares Outstanding 451.8M
Average Volume (1 week) 6.6M
Average Volume (1 Month) 11.5M
52 Week Change -64.38%
52 Week High 0.085
52 Week Low 0.022
Spread (Intraday) 0 (3.7%)

Company Info

Company Name Radiopharm Theranostics Limited
Address level 3
melbourne, victoria 3053
Website https://www.radiopharmtheranostics.com
Industry in vitro,in vivo diagnostics (2835)

Your Recent History

Delayed Upgrade Clock